{
    "id": "645ea9e5-c2f5-40ef-85cd-3c1b5d8d0f27",
    "indications": {
        "text": "diprivan intravenous general anesthetic sedation indicated : \u2022induction general anesthesia patients greater equal 3 years age \u2022maintenance general anesthesia patients greater equal 2 months age \u2022initiation maintenance monitored anesthesia care ( mac ) sedation adult patients \u2022sedation adult patients combination regional anesthesia \u2022intensive care unit ( icu ) sedation intubated , mechanically ventilated adult patients limitations diprivan recommended induction anesthesia age 3 years maintenance anesthesia age 2 months safety effectiveness established [ pediatric ( 8.4 ) ] . safety , effectiveness dosing guidelines diprivan established mac sedation pediatric population ; therefore , recommended [ pediatric ( 8.4 ) ] . diprivan indicated pediatric icu sedation since safety regimen established [ pediatric ( 8.4 ) ] .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "full prescribing information detailed dosing instructions .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "diprivan ( propofol ) injectable emulsion , usp available follows : product code unit sale strength prx260929 ndc 63323-269-4320 ml ready-to-use single-dose vial single patient . ndc 63323-269-94packages ten . 200 mg per 20 ml ( 10 mg per ml ) prx260950 ndc 63323-269-4550 ml ready-to-use single-dose vial single patient . ndc 63323-269-59packages twenty . 500 mg per 50 ml ( 10 mg per ml ) prx260965 ndc 63323-269-41100 ml ready-to-use single-dose vial single patient . ndc 63323-269-69packages ten . 1,000 mg per 100 ml vial ( 10 mg per ml ) store 4\u00b0c 25\u00b0c ( 40\u00b0f 77\u00b0f ) . freeze . shake well .",
    "adverseReactions": "diprivan contraindicated patients known hypersensitivity propofol diprivan components . diprivan contraindicated patients history anaphylaxis eggs , egg products , soybeans soy products .",
    "ingredients": [
        {
            "name": "PROPOFOL",
            "code": "YI7VU623SF",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_44915"
        },
        {
            "name": "SOYBEAN OIL",
            "code": "241ATL177A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_166975"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX",
            "drugbank_id": "https://go.drugbank.com/drugs/DB09462"
        },
        {
            "name": "EGG PHOSPHOLIPIDS",
            "code": "1Z74184RGV",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14233"
        },
        {
            "name": "EDETATE DISODIUM ANHYDROUS",
            "code": "8NLQ36F6MM",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14600"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        }
    ],
    "organization": "Fresenius Kabi USA, LLC",
    "name": "Diprivan",
    "effectiveTime": "20250421",
    "indications_original": "DIPRIVAN is an intravenous general anesthetic and sedation drug indicated for: \n                  \n                     \n                        \u2022Induction of General Anesthesia for Patients Greater than or Equal to 3 Years of Age\n                     \n                        \u2022Maintenance of General Anesthesia for Patients Greater than or Equal to 2 Months of Age\n                     \n                        \u2022Initiation and Maintenance of Monitored Anesthesia Care (MAC) Sedation in Adult Patients\n                     \n                        \u2022Sedation for Adult Patients in Combination with Regional Anesthesia\n                     \n                        \u2022Intensive Care Unit (ICU) Sedation of Intubated, Mechanically Ventilated Adult Patients\n                  \n                  \n                     Limitations of Use\n                  \n                  DIPRIVAN is not recommended for induction of anesthesia below the age of 3 years or for maintenance of anesthesia below the age of 2 months because its safety and effectiveness have not been established in those populations [see Pediatric Use (8.4)]. \n                  Safety, effectiveness and dosing guidelines for DIPRIVAN have not been established for MAC sedation in the pediatric population; therefore, it is not recommended for this use [see Pediatric Use (8.4)]. \n                  \n                  DIPRIVAN is not indicated for use in Pediatric ICU sedation since the safety of this regimen has not been established [see Pediatric Use (8.4)].",
    "contraindications_original": "See Full Prescribing Information for detailed dosing instructions.",
    "warningsAndPrecautions_original": "DIPRIVAN (propofol) injectable emulsion, USP is available as follows:\n                  \n                     \n                     \n                     \n                     \n                     \n                        \n                           \n                              \n                                 Product Code\n                              \n                           \n                           \n                              \n                                 Each\n                              \n                           \n                           \n                              \n                                 Unit of Sale\n                              \n                           \n                           \n                              \n                                 Strength\n                              \n                           \n                        \n                        \n                           \n                              PRX260929\n                           \n                           \n                              NDC 63323-269-4320 mL ready-to-use single-dose vial for single patient use only.\n                           \n                           \n                              NDC 63323-269-94Packages of ten.\n                           \n                           \n                              200 mg per 20 mL(10 mg per mL)\n                           \n                        \n                        \n                           \n                              PRX260950\n                           \n                           \n                              NDC 63323-269-4550 mL ready-to-use single-dose vial for single patient use only.\n                           \n                           \n                              NDC 63323-269-59Packages of twenty.\n                           \n                           \n                              500 mg per 50 mL(10 mg per mL)\n                           \n                        \n                        \n                           \n                              PRX260965\n                           \n                           \n                              NDC 63323-269-41100 mL ready-to-use single-dose vial for single patient use only.\n                           \n                           \n                              NDC 63323-269-69Packages of ten.\n                           \n                           \n                              1,000 mg per 100 mL vial(10 mg per mL)\n                           \n                        \n                     \n                  \n                  Store between 4\u00b0C to 25\u00b0C (40\u00b0F to 77\u00b0F). Do not freeze.\u00a0Shake well before use.",
    "adverseReactions_original": "DIPRIVAN is contraindicated in patients with a known hypersensitivity to propofol or any of DIPRIVAN components.\n                  DIPRIVAN is contraindicated in patients with a history of anaphylaxis to eggs, egg products, soybeans or soy products.",
    "drug": [
        {
            "name": "Diprivan",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_44915"
        }
    ]
}